ANNEXON BIOSCIENCES

Live / Registered — Registered (as of 11 Aug 2026)

What this means for you

Registered since 11 Aug 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Aug 2032: the §8 declaration of use).

Record

Serial number
98978455
Registration number
8394643
Mark type
Word mark
Filed
12 Aug 2024
Published for opposition
18 Mar 2025
Registered
11 Aug 2026
Next maintenance filing
§8 declaration of use, due by 11 Aug 2032 (grace period to 11 Feb 2033)
Attorney of record
Joshua S. Jarvis, Esq.

Goods and services

  • Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immune system related diseases and disorders, complement-mediated diseases and disorders, neurological diseases and disorders, and ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of Guillain-Barré syndrome, macular degeneration, and geographic atrophy
  • Class 042 — Scientific and technological services: Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
  • Class 044 — Medical, beauty and agricultural services: Providing medical information; providing medical information related to pharmaceuticals

Owner

Prosecution history

  • 11 Aug 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 11 Aug 2026 — REGISTERED-PRINCIPAL REGISTER
  • 20 Jul 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 20 Jul 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 13 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 12 Jun 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 11 Sept 2025 — USE AMENDMENT FILED
  • 12 Jun 2026 — SOU EXTENSION 1 GRANTED
  • 10 Sept 2025 — SOU EXTENSION 1 FILED
  • 12 Jun 2026 — DIVISIONAL PROCESSING COMPLETE
  • 11 Sept 2025 — DIVISIONAL REQUEST RECEIVED
  • 10 Jun 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 11 Sept 2025 — TEAS REQUEST TO DIVIDE RECEIVED
  • 19 Mar 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
  • 11 Sept 2025 — TEAS STATEMENT OF USE RECEIVED

View this trademark record on Rightsy